Trials / Conditions / Solid Tumors Harboring NTRK Fusion

Solid Tumors Harboring NTRK Fusion

9 registered clinical trials studyying Solid Tumors Harboring NTRK Fusion — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harb NCT07394374	Cullgen (Shanghai),Inc	Phase 1 / Phase 2
Completed	A Study Called VICTORIA to Learn More About How Well Larotrectinib Works in Adults With TRK Fusion-positive Ca NCT05192642	Bayer	—
Completed	Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as T NCT04771390	Bayer	Phase 1
Completed	Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Exc NCT04275960	Bayer	Phase 1
Completed	A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Can NCT03215511	Bayer	Phase 1
Active Not Recruiting	A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion NCT02637687	Bayer	Phase 1 / Phase 2
Completed	A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tu NCT02576431	Bayer	Phase 2
Completed	A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer NCT02122913	Bayer	Phase 1
No Longer Available	Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion NCT03206931	Bayer	—